We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$770M
AUM Growth
-$139M
Cap. Flow
-$148M
Cap. Flow %
-19.28%
Top 10 Hldgs %
27.93%
Holding
310
New
93
Increased
84
Reduced
76
Closed
52

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$29.8M
2
ELV icon
Elevance Health
ELV
+$27.4M
3
CVS icon
CVS Health
CVS
+$26.6M
4
COR icon
Cencora
COR
+$25.7M
5
AAPL icon
Apple
AAPL
+$23.2M

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.09%
2 Technology 17.11%
3 Consumer Discretionary 15.7%
4 Healthcare 10.45%
5 Industrials 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VZ icon
101
Verizon
VZ
$195B
$760K 0.1%
14,054
+7,158
+104% +$358K
PPBI
102
DELISTED
Pacific Premier Bancorp
PPBI
$759K 0.1%
35,507
-870
-2% -$17.8K
SNC
103
DELISTED
State National Companies, Inc.
SNC
$758K 0.1%
+60,149
New +$649K
MANH icon
104
Manhattan Associates
MANH
$11.2B
$753K 0.1%
13,235
-33,508
-72% -$1.86M
WEC icon
105
WEC Energy
WEC
$35.7B
$746K 0.1%
12,421
+4,834
+64% +$271K
CBRL icon
106
Cracker Barrel
CBRL
$1.26B
$714K 0.09%
4,676
+1,146
+32% +$158K
BAX icon
107
Baxter International
BAX
$13.5B
$713K 0.09%
17,352
+696
+4% +$26.5K
XRAY icon
108
Dentsply Sirona
XRAY
$2.68B
$708K 0.09%
+11,481
New +$677K
BXLT
109
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$697K 0.09%
17,252
+796
+5% +$31.5K
RGR icon
110
Sturm, Ruger & Co
RGR
$594M
$683K 0.09%
+9,990
New +$651K
SYNH
111
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$662K 0.09%
16,065
+9,350
+139% +$385K
GAS
112
DELISTED
AGL Resources Inc
GAS
$662K 0.09%
10,168
-135
-1% -$8.69K
PKG icon
113
Packaging Corp of America
PKG
$21.9B
$661K 0.09%
10,947
+5,385
+97% +$288K
PGX icon
114
Invesco Preferred ETF
PGX
$3.81B
$638K 0.08%
42,739
+19,457
+84% +$286K
ETN icon
115
Eaton
ETN
$161B
$627K 0.08%
10,027
+4,936
+97% +$273K
LGND icon
116
Ligand Pharmaceuticals
LGND
$5.76B
$617K 0.08%
9,230
-6,202
-40% -$377K
ORA icon
117
Ormat Technologies
ORA
$6B
$607K 0.08%
+14,716
New +$546K
LXFT
118
DELISTED
Luxoft Holding, Inc.
LXFT
$602K 0.08%
10,947
-4,790
-30% -$288K
MSEX icon
119
Middlesex Water
MSEX
$1.08B
$580K 0.08%
18,815
+7,760
+70% +$220K
HELE icon
120
Helen of Troy
HELE
$644M
$565K 0.07%
5,451
+24
+0.4% +$2.24K
HPP
121
Hudson Pacific Properties
HPP
$747M
$561K 0.07%
2,771
-37
-1% -$6.72K
RYAAY icon
122
Ryanair
RYAAY
$30.4B
$557K 0.07%
+16,228
New +$535K
ABBV icon
123
AbbVie
ABBV
$443B
$544K 0.07%
+9,516
New +$530K
WU icon
124
Western Union
WU
$1.98B
$520K 0.07%
26,963
+12,251
+83% +$220K
NAII icon
125
Natural Alternatives International
NAII
$14.4M
$514K 0.07%
+38,012
New +$387K

Similar funds

Navellier & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Navellier & Associates held 310 positions worth $770M, down 15% from $909M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Navellier & Associates withdrew a net $148M in Q1 2016, closing 52 positions and reducing 76 holdings. Its most notable exit was NXP Semiconductors, an estimated $29.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Navellier & Associates opened a new position in Hormel Foods worth $18M.

  • Navellier & Associates's largest Q1 2016 buy was Hormel Foods: 417,152 shares worth $18M.
  • Navellier & Associates added most to Reynolds American Inc in Q1 2016, an estimated $13.2M increase.
  • Navellier & Associates's biggest Q1 2016 reduction was Apple, cutting an estimated $23.2M.
  • Navellier & Associates fully exited NXP Semiconductors in Q1 2016, selling an estimated $29.8M.
  • Navellier & Associates's ten largest holdings make up 28% of its $770M portfolio in Q1 2016.
  • Navellier & Associates opened 93 new positions and closed 52 in Q1 2016.
  • Navellier & Associates's portfolio value fell 15% quarter-over-quarter to $770M.

Based on Navellier & Associates's 13F filing for Q1 2016, filed 13 May 2016.